This study investigated whether anticoagulants were effective at preventing second stroke in patients with atrial fibrillation, and when treatment should be started. They concluded that anticoagulants are more effective than antiplatelets, and are most effective when administered between 4 and 14 days after the first stroke.

This study looked at the risk of blood clots in patients with rheumatoid arthritis (RA) treated with biologics. It found that there was no significant increase in the risk of blood clots with biologics compared to other RA treatments.

This study examined whether empagliflozin was safe and effective in combination with metformin and a sulfonylurea in the long-term treatment of type 2 diabetes.

This paper studied the effect of stopping antiplatelet therapy following stent placement. 

This study investigated the occurrence of fatigue (tiredness) in patients with early rheumatoid arthritis (RA) and identified predictors of fatigue after 24 months. The data showed that patients with early disease remission had a rapid, sustained reduction in fatigue and that low disease activity at diagnosis predicted a higher risk of fatigue at 24 months.

This study compared the therapeutic benefit of topically applied ON101 (Fespixon) cream to an absorbent dressing (Hydrofiber; ConvaTec Ltd) on wound healing in patients with chronic diabetic foot ulcers (DFUs). The authors concluded that the therapeutic effectiveness of ON101 treatment of DFUs was better compared to absorbent dressing.

This study is aimed to evaluate the risk of infection for patients who are treated with immune checkpoint inhibitors (ICI) for solid tumors. The study concluded that in frail patients, ICI therapy alone is safer compared to chemotherapy (CT).  

This paper studied the effect of loop diuretics in patients with suspected coronary artery disease but without heart failure. 

This study investigated whether kisspeptin-54 could be used to increase egg yield in women undergoing IVF and at risk of ovarian hyperstimulation syndome (OHSS). This study concluded that kisspeptin-54 effectively triggered ovulation with a low risk of OHSS.

This study explored the risk factors for fragility fractures in patients with rheumatoid arthritis (RA). The authors concluded that aging, disease-related factors, and previous fracture history are important risk factors for fragility fractures in these patients.